Eikance 0.025%, Eikance 0.05% Aspen Pharmacare Australia Pty Ltd
Product name
Eikance 0.025%, Eikance 0.05%
Accepted date
Jul-2023
Active ingredients
atropine sulfate monohydrate
Proposed indication
As a treatment to slow the progression of myopia in children.
Application type
C (new indication)
Publication date
Jul-2023